Details
| Stereochemistry | MIXED |
| Molecular Formula | C19H40 |
| Molecular Weight | 268.5209 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CCCC(C)CCCC(C)CCCC(C)C
InChI
InChIKey=XOJVVFBFDXDTEG-UHFFFAOYSA-N
InChI=1S/C19H40/c1-16(2)10-7-12-18(5)14-9-15-19(6)13-8-11-17(3)4/h16-19H,7-15H2,1-6H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Contribution of mast cell mediators to alterations in macrophage function after malathion administration. | 1996 Sep |
|
| Biosynthesis of fatty acids and triacylglycerols by 2,6,10,14-tetramethyl pentadecane-grown cells of Nocardia globerula 432. | 2001 Jun 25 |
|
| Microstructure determination of AOT + phenol organogels utilizing small-angle X-ray scattering and atomic force microscopy. | 2001 Mar 14 |
|
| Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats. | 2003 |
|
| Degradation of alkanes and highly chlorinated benzenes, and production of biosurfactants, by a psychrophilic Rhodococcus sp. and genetic characterization of its chlorobenzene dioxygenase. | 2003 Oct |
|
| Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus. | 2003 Sep |
|
| Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice. | 2004 Apr 15 |
|
| Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. | 2004 Jul |
|
| Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity. | 2005 |
|
| Effects of pristane on cytochrome P450 isozyme expression in rat tissues. | 2005 Apr |
|
| Isolation and characterization of Rhodococcus sp. strains TMP2 and T12 that degrade 2,6,10,14-tetramethylpentadecane (pristane) at moderately low temperatures. | 2005 Jan 26 |
|
| Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). | 2006 Apr |
|
| Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses. | 2006 Oct 30 |
|
| A new arthritis therapy with oxidative burst inducers. | 2006 Sep |
|
| Headspace-mass spectrometry determination of benzene, toluene and the mixture of ethylbenzene and xylene isomers in soil samples using chemometrics. | 2007 Mar 21 |
|
| Arthritis suppression by NADPH activation operates through an interferon-beta pathway. | 2007 May 9 |
|
| Deficiency of the type I interferon receptor protects mice from experimental lupus. | 2007 Nov |
|
| The determinants of susceptibility/resistance to adjuvant arthritis in rats. | 2009 |
|
| Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. | 2009 |
|
| B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus. | 2009 Apr 1 |
|
| Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. | 2009 Nov |
|
| High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus. | 2010 |
|
| Bioconversion of 2,6-dimethylpyridine to 6-methylpicolinic acid by Exophiala dermatitidis (Kano) de Hoog DA5501 cells grown on n-dodecane. | 2010 Apr |
|
| Immunomodulatory strategies prevent the development of autoimmune emphysema. | 2010 Dec 16 |
|
| MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats. | 2014 Jan 14 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C44351
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
53181
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
C29850
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | NCIT | ||
|
26HZV48DT1
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
8345
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
DTXSID70870919
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
m9140
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | Merck Index | ||
|
1921-70-6
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
114852
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
217-650-8
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
15979
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
C009042
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
PRISTANE
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
